InvestorsHub Logo
Followers 3421
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

Re: $heff post# 82702

Thursday, 08/21/2014 11:30:04 AM

Thursday, August 21, 2014 11:30:04 AM

Post# of 97237
Beginner Portfolio Update..re-entered a position of a company with pending catalysts at $2.16 here. Catalysts are on deck over the next few weeks. Traded it from $1.91 to $2.35 yesterday for a 23% gain. It closed at $2.35 yesterday as well.

Alert..re-entered $SYN at $2.16 for a solid starter trade. Will add on pullbacks. Catalysts are upcoming that will be strong for the company.

Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC
http://finance.yahoo.com/news/synthetic-biologics-announces-breaking-poster-105600116.html

$SYN SVP Dr. Kaleko to present a late-breaking poster on our #Cdiff program at #ICAAC Sept 6 at 12pm ET http://t.co/pVIDORW2c6

Synthetic Biologics to Host Irritable Bowel Syndrome (IBS) Investor Day.
http://finance.yahoo.com/news/synthetic-biologics-host-irritable-bowel-105600245.html

Mr. Riley added that near-term calendar events include a planned September 12th presentation at the 2014 Joint Americas and European Committees for Treatment and Research in Multiple Sclerosis Meeting (ACTRIMS-ECTRIMS) in Boston of additional Trimesta MS data, including important new findings in cognitive function, and a Company-sponsored IBS Investor Day planned for September 16th in NYC which will include clinical presentations by Mark Pimentel, M.D., FRCP(C) of Cedars-Sinai Medical Center, the lead investigator of our 505(b)(2) compound, SYN-010 for constipation-predominant irritable bowel syndrome (C-IBS).

Disclaimer: http://bit.ly/OlN9DB

Sheff's Station...All Aboard...Sign Up Here!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.